STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] ENSIGN GROUP, INC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 filed for Ensign Group, Inc. (ENSG) reports a proposed sale of 700 common shares through Fidelity Brokerage Services with an aggregate market value of $120,400, approximately 700 of the company's 57,700,157 outstanding shares, with an approximate sale date of 10/01/2025 on NASDAQ. The filing lists prior sales by the same person on 07/01/2025, 08/01/2025, and 09/02/2025, each of 700 shares with gross proceeds shown. Acquisition details show the shares were received as restricted stock vesting on 01/15/2022 and 01/18/2023 as compensation.

Positive
  • Transparent disclosure of the proposed sale, broker, and aggregate market value
  • History of recent sales in the past three months is provided, increasing transparency
  • Acquisition details show shares were received as restricted stock vesting (compensation), clarifying origin
Negative
  • Insider sales occurred repeatedly over several months (July, August, September 2025), which may attract investor attention

Insights

TL;DR: Small, routine insider sales disclosed; unlikely to be material to ENGS's capitalization but worth noting for trading transparency.

The filing details a proposed sale of 700 shares valued at $120,400 to be executed via Fidelity on NASDAQ on 10/01/2025. The seller previously executed three identical-sized sales in the prior three months, indicating ongoing disposition of vested restricted shares granted as compensation. Given the company-wide share count of 57,700,157, the transaction size is immaterial to overall capitalization. The pattern is consistent with routine insider liquidity events rather than a one-time large disposition.

TL;DR: Disclosure complies with Rule 144 requirements; signatures and representation language included, supporting regulatory transparency.

The form includes required representations about absence of undisclosed material information and documents the nature of acquisition as restricted stock vesting. It identifies the broker and provides prior three-month sales, aligning with disclosure expectations. No evidence in the filing of a Rule 10b5-1 plan or other instructions is provided. From a governance perspective, the filing meets procedural norms for insider sales reporting.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ENGS Form 144 report?

The filing reports a proposed sale of 700 common shares valued at $120,400 with an approximate sale date of 10/01/2025 on NASDAQ.

Who is the broker handling the sale in the ENGS filing?

The broker named is Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield RI.

Were there recent sales by the same person before this Form 144?

Yes. The filing lists sales of 700 shares on 07/01/2025, 08/01/2025, and 09/02/2025 with gross proceeds shown for each.

How were the shares acquired according to the filing?

The shares were acquired through restricted stock vesting on 01/15/2022 (451 shares) and 01/18/2023 (249 shares) as compensation.

How large is the proposed sale relative to outstanding shares?

The proposed 700-share sale is out of 57,700,157 outstanding shares, making it immaterial in scale to total capitalization.
Ensign Group Inc

NASDAQ:ENSG

ENSG Rankings

ENSG Latest News

ENSG Latest SEC Filings

ENSG Stock Data

10.39B
55.92M
3.43%
94.65%
3.17%
Medical Care Facilities
Services-skilled Nursing Care Facilities
Link
United States
SAN JUAN CAPISTRANO